FILING ANALYSIS · TUESDAY, OCTOBER 13
ONCOLYTICS BIOTECH INC ONCY — 8-K: Other Events
neutral
Oncolytics Biotech Inc. has secured new patent protection for its immunotherapy pelareorep, with expected issuance in the US and plans to expand its portfolio, but this update is routine and already priced in, lacking quantified surprises.
How we read impact: we grade every directional call in the open. Impact labels are AI estimates — not investment advice. See the full disclaimer.
Get filings like this every market day
The US SEC filings, UK RNS, EU notices, and Polymarket odds that matter — scored by AI, in one email.
Subscribe free →